Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Semaglutide mimics the action of the natural protein glucagon-like peptide 1 ... meaning its molecules mimic the structure of GLP-1, binding to its receptor like a counterfeit key someone ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The situation is causing the FDA regulatory headaches and, more seriously, posing ...

Ozempic, known medically as semaglutide, was originally designed to help adult ... cardiovascular disease or who are not classified as obese, we suggest that cardiac structure and function be ...

Inflammation was measured by levels of high-sensitivity C-reactive protein (hsCRP), which is a ... researchers found that once weekly semaglutide (2.4 mg) improved multiple domains of cardiac ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was originally approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes (T2D). Current ...

Semaglutide could help people drink less alcohol. Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less ...

GLP-1 agonists mimic the natural hormone glucagon-like peptide-1 (GLP-1), produced in ... Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic.